ArticleJournal of pharmaceutical analysis2025

Naringenin: A potential therapeutic agent for modulating angiogenesis and immune response in hepatocellular carcinoma.

Wenmei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.